<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Eskesen McHugh | Activity</title>
	<link>https://www.catswannabecats.com/members/lilacslope4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/lilacslope4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Eskesen McHugh.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">14613d57c438152fbe106ac3fb4eb1c6</guid>
				<title>Eskesen McHugh posted an update: Urolithin A impeded the TNFα-induced barrier loss by [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19546/</link>
				<pubDate>Thu, 05 Jun 2025 07:56:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>Urolithin A impeded the TNFα-induced barrier loss by inhibition of claudin-1 and -2 protein expression upregulation and claudin-1 delocalization in HT-29/B6. Conclusion Ellagic acid and urolithin A affect intestinal barrier function in distinct ways. Ellagic acid acts preventive by strengthening the barrier per se, while urolithin A protects&hellip;<span class="activity-read-more" id="activity-read-more-19546"><a href="https://www.catswannabecats.com/activity/p/19546/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">690a59e5a82432851a13b164fdb3da3b</guid>
				<title>Eskesen McHugh posted an update: The treatment protocol was changed to an amrubicin [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7778/</link>
				<pubDate>Sat, 31 May 2025 19:57:25 -0400</pubDate>

									<content:encoded><![CDATA[<p>The treatment protocol was changed to an amrubicin monotherapy regimen. However, the patient&#8217;s general condition worsened after the therapies, and he died 38 months after the surgery.Pancreatic neuroendocrine tumor(p-NET)is a relatively rare disease, and treatment is multidisciplinary with resection, local therapy, radiotherapy, and chemotherapy.&hellip;<span class="activity-read-more" id="activity-read-more-7778"><a href="https://www.catswannabecats.com/activity/p/7778/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f3e7e79ff3e6b50c9043ea1f25741aea</guid>
				<title>Eskesen McHugh posted an update: The treatment protocol was changed to an amrubicin [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7734/</link>
				<pubDate>Sat, 31 May 2025 19:52:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>The treatment protocol was changed to an amrubicin monotherapy regimen. However, the patient&#8217;s general condition worsened after the therapies, and he died 38 months after the surgery.Pancreatic neuroendocrine tumor(p-NET)is a relatively rare disease, and treatment is multidisciplinary with resection, local therapy, radiotherapy, and chemotherapy.&hellip;<span class="activity-read-more" id="activity-read-more-7734"><a href="https://www.catswannabecats.com/activity/p/7734/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fe88cbe5301e24679d9c71ed33b8bf86</guid>
				<title>Eskesen McHugh became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/6764/</link>
				<pubDate>Sat, 31 May 2025 17:12:37 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>